Posted on April 27th, 2012, 9:53 am
MarketWatch (press release) SAN MATEO, Calif., Apr 27, 2012 (GlobeNewswire via COMTEX) -- NeurogesX, Inc. (NASDAQ:NGSX) , a specialty pharmaceutical company focused on developing and commercializing a portfolio of novel non-opioid, pain management therapies, today announced it ... |